Method of culturing nk cells and kits containing medium additions
Abstract
A kit for use in adding to a cultural medium for culturing natural killer (NK) cells includes a B unit including a basic solution including IL-2, L-glutamine dissolved in a cell culture medium, a C1 unit including of a cytokine 1 solution including IL-12 and IL-18 dissolved in the basic solution, a C2 unit including of a cytokine 2 solution including IL-15 dissolved in the basic solution, an A1 unit including of an antibody 1 solution including an anti-CD16 antibody and an anti-CD56 antibody dissolved in the basic solution, an A2 unit including of an antibody 2 solution including the antibody 1 solution and the basic solution in a volume ratio of 1:6-10, and a D unit including of an antibody-cytokine mixed solution including an anti-CD3 antibody dissolved in the cytokine 1 solution.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A kit for use in adding to a cultural medium for culturing natural killer (NK) cells, the kit comprising:
a B unit comprising a basic solution comprising IL-2, L-glutamine dissolved in a cell culture medium; a C1 unit comprising of a cytokine 1 solution comprising IL-12 and IL-18 dissolved in the basic solution; a C2 unit comprising of a cytokine 2 solution comprising IL-15 dissolved in the basic solution; an A1 unit comprising of an antibody 1 solution comprising an anti-CD16 antibody and an anti-CD56 antibody dissolved in the basic solution; an A2 unit comprising of an antibody 2 solution comprising the antibody 1 solution and the basic solution in a volume ratio of 1:6-10; and a D unit comprising of an antibody-cytokine mixed solution comprising an anti-CD3 antibody dissolved in the cytokine 1 solution.
2 . The kit of claim 1 , wherein the A1 unit is added to the lymphocyte culture medium prior to the D unit.
3 . The kit of claim 1 , wherein the anti-CD16 antibody, the anti-CD56 antibody and the basic solution of the A1 unit are separately packaged and mixed during the medium addition step.
4 . The kit of claim 1 , wherein the anti-CD16 antibody, the anti-CD56 antibody and the basic solution of the A2 unit are separately packaged and mixed during the medium addition step.
5 . The kit of claim 1 , wherein anti-CD3 antibody and the cytokine 1 solution of the D unit are separately packaged and mixed during the medium addition step.
6 . The kit of claim 1 , wherein the units are configured to be added to a lymphocyte culture medium in the order of the A1 unit, the D unit, the C1 unit, the A2 unit, the C2 unit, the A2 unit and the B unit.
7 . A culture medium for culturing natural killer (NK) cell, the culture medium comprising the kit of claim 1 .
8 . The culture medium of claim 7 , wherein the culture medium is obtained by culturing NK cells for 8 days or less, and the number of NK cells contained in the culture medium is 5×10 7 or more.
9 . The culture medium of claim 7 , wherein the number of NK cells contained in the culture medium is 2×10 9 or more, and the ratio of NK cells is 80% or more.
10 . The culture medium of claim 7 , wherein the number of NK cells contained in the culture medium is 2×10 9 or more, and the ratio of NK cells is 80% or more.Join the waitlist — get patent alerts
Track US2023203444A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.